David Klonoff to United States
This is a "connection" page, showing publications David Klonoff has written about United States.
Connection Strength
0.159
-
Telemedicine for Diabetes After the COVID-19 Pandemic: We Can't Put the Toothpaste Back in the Tube or Turn Back the Clock. J Diabetes Sci Technol. 2020 Jul; 14(4):741-742.
Score: 0.031
-
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. J Diabetes Sci Technol. 2020 Jul; 14(4):813-821.
Score: 0.031
-
A Review of Blood Glucose Monitor Accuracy. Diabetes Technol Ther. 2018 12; 20(12):843-856.
Score: 0.027
-
Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors. Diabetes Care. 2018 08; 41(8):1681-1688.
Score: 0.027
-
Performance of Cleared Blood Glucose Monitors. J Diabetes Sci Technol. 2015 Jul; 9(4):895-910.
Score: 0.022
-
Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic. J Diabetes Sci Technol. 2020 Jul; 14(4):822-832.
Score: 0.008
-
Allen M. Spiegel, M.D., named Director of NIDDK. Diabetes Technol Ther. 2000; 2(1):123.
Score: 0.007
-
Open Source Closed-Loop Insulin Delivery Systems: A Clash of Cultures or Merging of Diverse Approaches? J Diabetes Sci Technol. 2018 11; 12(6):1223-1226.
Score: 0.007